CLLSA Meeting 15th October at St Edmund Hall - CLL Support
CLLSA Meeting 15th October at St Edmund Hall
You need to be a member of this community to see this post.
Read more about...
14 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL
000 patients from three German CLL Study Group clinical trials has identified that unfit patients...
Chemo-Free Treatment Best Option for CLL Patients Under 70
grouping of fludarabine, cyclophosphamide, and rituximab, known as FCR.
READ MORE:...
Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
Haematology Good Practice Paper 2022...
UK NICE Approves Ibrutinib +Venetoclax for First Line treatment for ALL Patients from today
ALL CLL patients as their first treatment if their doctor feels it is appropriate. This treatment...
Early results of the Pirtobrutinib, Obinituzumab, Venetoclax trial I'm on have just been published
VENETOCLAX, AND OBINUTUZUMAB INFIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA...
Related Posts
- A Reminder of the Symptoms of Shingles including the pre Rash phase.
- Forget fad diets – this is what you should eat
- Progression Free Survival (PFS) post Discontinuation of Ibrutinib in E1912 Trial
- Adding Venetoclax to Obinutuzumab Prolongs Progression-Free Survival in Previously Untreated CLL
STORM CHASER MISSES THE TARGET
